# Aura Biosciences, Inc.: Form 8-K, filed Mar 27, 2024

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 8-K
- Filed: 2024-03-27
- Accepted by EDGAR: Mar 27, 2024, 07:05 ET
- Period: 2024-03-27
- Accession: 0000950170-24-036811
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036811/aura-20240327.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000095017024036811/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000095017024036811/aura-20240327.htm

Filed Mar 27, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-036811. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.